Sentence examples for completing primary chemotherapy from inspiring English sources

Patients with progressive disease during primary chemotherapy or those who suffered recurrent disease within 6 months of completing primary chemotherapy were termed paclitaxel-resistant. Patients with recurrence beyond 6 months or without recurrence were termed paclitaxel-sensitive. Overall survival time (OS) was calculated as the time from surgery to the last follow-up date or death.

Individuals with a personal history of ductal carcinoma in situ (DCIS), Stage I, or Stage IIA breast cancer were eligible provided that at least 6 months had elapsed since completing primary therapy (surgery, radiation, or chemotherapy).

The final response was assessed within 1 month of completing the primary chemotherapy, with follow-up restaging every 3 months during the first year, and every 6 months thereafter.

Patients are required to have completed primary surgery and/or chemotherapy, if indicated.

A total of 213 consecutive eligible postmenopausal patients who had histologically confirmed hormone receptor-positive breast cancer and who had completed primary surgery and chemotherapy (if indicated) and were scheduled to receive anastrozole were enrolled in the ARBI study.

All had completed primary surgery and received 6 cycles of anthracycline-containing chemotherapy.

In the ATAC trial, postmenopausal women with early (invasive, operable) breast cancer who had completed primary therapy (surgery±radiotherapy±chemotherapy) and who were eligible for adjuvant hormonal therapy were randomised to receive either anastrozole or tamoxifen (or both) for up to 5 years (ATAC Trialists Groupp, 2005).

Patients who achieve a serological complete response after primary chemotherapy, but are left with ≤ 2 cm radiological masses that are not cystic and have responded, can be safely observed with diligent follow-up.

Ring et al (2003) found, in a retrospective study comparing surgery (either breast-conserving or mastectomy) and exclusive radiotherapy for women who achieved clinical complete responses after primary chemotherapy, a nonsignificant trend toward increased locoregional-only recurrence for the no surgery group.

All patients completed a treatment plan including primary chemotherapy, surgery, radiation therapy, adjuvant chemotherapy, and hormone therapy, when indicated (see below).

Recent publications have shown a positive relationship between a gene expression signature and a complete pathological response to primary chemotherapy [ 30, 31].